IP Verse

Almirall competitive analysis

Latest patents of Almirall opposed by its competitors

Explore Almirall's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 10, 2026
Patent NumberPublication DateTitleTotal Oppositions
EP2265257
Oct 25, 2023Inhalation Composition Containing Aclidinium For Treatment Of Asthma And Chronic Obstructive Pulmonary Disease2
EP2265258
Oct 7, 2015Inhalation Composition Containing Aclidinium For Treatment Of Asthma And Chronic Obstructive Pulmonary Disease1
EP2315581
Dec 17, 2014Topical Composition For The Treatment Of Actinic Keratosis1

Latest PTAB cases involving Almirall

Discover the latest PTAB cases involving Almirall, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 14, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Almirall

IPR2019-01095Jun 7, 2019MYLAN PHARMACEUTICALSALMIRALLFinal Written Decision
IPR2019-00207Nov 6, 2018AMNEAL PHARMACEUTICALSALMIRALLFinal Written Decision
IPR2018-00608Feb 12, 2018AMNEAL PHARMCEUTICALSALMIRALLFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Almirall with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 10, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ALMIRALL - 3 - 3
AMNEAL PHARMACEUTICALS - - 32 -
AMNEAL PHARMCEUTICALS - - 1 -
GENERICS UK319 - - -